Ischemia-reperfusion (I/R) injury is a leading cause of acute renal dysfunction. Remote ischemic conditioning (rIC) is known to protect organs exposed to I/R. We sought to investigate whether rIC would influence renal function recovery in a severe renal I/R injury rat model. Rats were randomly assigned to four experimental groups following median laparotomy and right nephrectomy: Sham (n = 6); 30-min left renal ischemia (RI) only (n = 20); RI+rIC (n = 20) (four 5-min cycles of limb ischemia interspersed with 5-min limb reperfusion during RI); RI+erythropoietin pre-treatment (EPO) (n = 20). Renal function was evaluated by assessing blood urea nitrogen (BUN) and serum creatinine (Cr) levels before surgery and after 1 day of reperfusion. All animals were monitored for 7 days for survival analysis. BUN and Cr baseline levels did not significantly differ between groups. At Day 1, BUN and Cr were significantly higher than baseline values in all groups. BUN and Cr levels did not significantly differ at Day 1 between RI and RI+rIC (p = 0.68). Conversely, EPO pre-treatment injected 60 minutes before RI was associated with lower BUN and Cr levels compared to RI (p < 0.001 and p = 0.003, respectively) and RI+rIC (p < 0.001 and p = 0.001, respectively). In addition, 7-day survival rates were significantly higher in the Sham group (100%) compared to RI (50%; p = 0.039 vs Sham) and RI+rIC (45%; p = 0.026 vs Sham). Conversely, survival rate did not significantly differ between the Sham and RI+EPO groups (70%, p = 0.15). In conclusion, rIC affected neither acute renal dysfunction nor early mortality in a severe I/R renal injury rat model, contrary to EPO pre-treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.